Cargando…
Risk in Vaccine Research and Development Quantified
To date, vaccination is the most cost-effective strategy to combat infectious diseases. Recently, a productivity gap affects the pharmaceutical industry. The productivity gap describes the situation whereby the invested resources within an industry do not match the expected product turn-over. While...
Autores principales: | Pronker, Esther S., Weenen, Tamar C., Commandeur, Harry, Claassen, Eric H. J. H. M., Osterhaus, Albertus D. M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603987/ https://www.ncbi.nlm.nih.gov/pubmed/23526951 http://dx.doi.org/10.1371/journal.pone.0057755 |
Ejemplares similares
-
Food-Pharma Convergence in Medical Nutrition– Best of Both Worlds?
por: Weenen, Tamar C., et al.
Publicado: (2013) -
Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis
por: Ramezanpour, Bahar, et al.
Publicado: (2015) -
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
por: Ramezanpour, Bahar, et al.
Publicado: (2016) -
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
por: Fernald, K. D. S., et al.
Publicado: (2017) -
Commentary: Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi-Species Validation and Evaluation in a Human Diagnostic Cohort
por: Clement, Jan, et al.
Publicado: (2021)